We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Olympus Signs Licensing Agreements with Omnyx

By LabMedica International staff writers
Posted on 11 Mar 2010
Print article
Olympus America Inc. (Center Valley, PA, USA) has signed a nonexclusive worldwide licensing agreement with Omnyx, LLC, (Pittsburgh, PA; and Piscataway, NJ, USA)--a joint venture of GE Healthcare (Fairfield, CT, USA) and the University of Pittsburgh Medical Center (UPMC; Pittsburgh, USA).

The agreement permits Omnyx to access the extensive portfolio of Olympus America patents in the field of virtual microscopy and digital pathology. The patents involved in the licensing agreement cover software and technology related to creating, storing, and delivering virtual microscopy images. The specific terms and conditions of the agreement are not being made public by the two companies.

Virtual microscope slides enable professionals to review biopsies and other pathology images without handling traditional glass slides, and allow doctors to share high-resolution digital microscope images over the Internet for remote pathology consultation.

The technology also has the potential to aid hospitals in moving to comprehensive patient Electronic Medical Record (EMR) systems--a transition that has already started in some areas of the world.

According to a 2010 report published by Laboratory Economics, US$13.2 billion was spent in anatomic pathology testing in the United States during 2008. The patented technologies will help deliver valuable images to doctors, streamline the review process, improve speed of reporting, save substantial expense, and enhance patient care.

Olympus works collaboratively with its customers and affiliates worldwide to leverage Research and Development (R&D) investment in precision technology and manufacturing processes across diverse business lines. These include advanced clinical, research, and educational microscopes and clinical digital imaging systems.

Related Links:

Olympus America Inc.
Omnyx, LLC
GE Healthcare
University of Pittsburgh Medical Center


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Newborn Screening Test
NeoMass AAAC 3.0
New
Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.